What is Dermatomyositis and Polymyositis

Dermatomyositis and polymyositis are rare, chronic inflammatory muscle diseases (idiopathic inflammatory myopathies) characterized by muscle weakness and, in the case of dermatomyositis, distinct skin rashes. These autoimmune conditions occur when the body’s immune system mistakenly attacks healthy muscle tissue, leading to progressive weakness and potential systemic complications.

What are the primary differences between Dermatomyositis and Polymyositis?

While both conditions fall under the umbrella of inflammatory myopathies, dermatomyositis is distinguished by characteristic skin manifestations, such as a heliotrope rash (a purplish-red discoloration on the eyelids) and Gottron’s papules (scaly, red bumps over the knuckles). Polymyositis, conversely, primarily affects the skeletal muscles without the hallmark skin involvement. Both conditions lead to symmetrical weakness, typically in the muscles closest to the trunk of the body, such as the hips, thighs, shoulders, and neck.

Which body systems are affected by these conditions?

The primary impact of dermatomyositis and polymyositis is on the skeletal muscles, causing difficulty with daily activities like climbing stairs, rising from a chair, or lifting objects. However, these diseases can affect other systems as well:

• Pulmonary: Interstitial lung disease (ILD) is a significant concern that can cause shortness of breath.


• Cardiac: Inflammation may occasionally affect the heart muscle (myocarditis) or rhythm.


• Gastrointestinal: Muscles involved in swallowing can be affected, leading to dysphagia.


• Skin: Specific to dermatomyositis, photosensitivity and systemic rashes are common.

How common are these conditions and who is affected?

These are rare diseases with an estimated combined annual incidence of approximately 2 to 10 cases per million people. Dermatomyositis and polymyositis can affect individuals of any age, though they most commonly present in adults between the ages of 40 and 60. Interestingly, dermatomyositis has a bimodal distribution, meaning it also has a peak incidence in childhood (juvenile dermatomyositis). Women are affected approximately twice as often as men across both conditions. Currently, 413 people with dermatomyositis and polymyositis are part of the DiseaseMaps.org community, highlighting that while rare, you are not alone in your journey.

What causes these diseases?

The exact cause of dermatomyositis and polymyositis remains unknown, but researchers classify them as autoimmune disorders. In these conditions, the immune system undergoes a dysregulation, leading to the production of autoantibodies that target muscle fibers or blood vessels within the skin and muscles. This process triggers chronic inflammation, which eventually degrades muscle tissue. Genetic predisposition, combined with environmental triggers such as viral infections or ultraviolet light exposure, is believed to play a role in initiating the disease process.

How are these conditions differentiated from others?

Clinicians differentiate dermatomyositis and polymyositis from other muscular dystrophies or metabolic muscle diseases through a combination of blood tests (monitoring elevated muscle enzymes like creatine kinase), electromyography (EMG), magnetic resonance imaging (MRI), and muscle biopsies. The presence of specific autoantibodies, such as anti-Jo-1 or anti-Mi-2, often provides diagnostic clarity that helps distinguish these inflammatory conditions from inherited genetic muscle disorders.

Next steps

• Consult a rheumatologist or a neurologist who specializes in neuromuscular diseases for a comprehensive evaluation.


• Maintain a symptom journal to track muscle weakness, skin changes, and fatigue to share with your medical team.


• Connect with others by joining the dermatomyositis and polymyositis community at DiseaseMaps.org to share experiences and coping strategies.


• Ask your physician about screening for associated conditions, such as interstitial lung disease.

Medical disclaimer: This information is for educational purposes only and does not constitute professional medical advice, diagnosis, or treatment; always seek the advice of your physician regarding a medical condition.

References

• Orphanet: Rare Disease Database (ORPHA: 593 and 732).


• NIH Genetic and Rare Diseases (GARD) Information Center.


• The Myositis Association: Patient Education and Research Resources.


• OMIM (Online Mendelian Inheritance in Man): Clinical summaries for inflammatory myopathies.